eMedicine Specialties > Emergency Medicine > Environmental
Snake Envenomation, Cobra
Updated: Dec 29, 2008
Introduction
Background
To many people, the cobra is the quintessential venomous snake. Cobras discussed in this article include species in the genus Naja and other similar venomous snakes, such as Ophiophagus hannah (king cobra), Hemachatus haemachatus (ringhals), Walterinnesia aegyptia (desert black snake), Boulengerina species (water cobras), and Pseudohaje species (tree cobras).
Most cobras are large snakes, 1.2-2.5 m in length. The king cobra, which may reach 5.2 m, is the largest venomous snake in the world. Cobras live throughout most of Africa and southern Asia. Their habitats vary, and some species adapt readily to life in cultivated areas and around villages.
When encountered, cobras usually try to escape but occasionally defend themselves boldly and may appear aggressive. Most of these snakes elevate the head and spread the neck as a threat gesture. However, a number of other snakes, venomous and nonvenomous, use this defense as well.
Most snakebites are inflicted on body extremities. Because cobras are popular as show snakes, bites on the hands and fingers are common.
By far, rural agricultural workers and other people in Asia and Africa receive most bites while working outdoors without protective footwear or when cutting tall grass with a hand blade. In North America and Europe, captive snakes usually cause bites, zookeepers and amateur collectors being at greatest risk.
Not all snakebites result in envenomation. In the case of cobras, the percentage of blank bites may be quite high, 45% in one series of 47 cases from Malaysia. In another series, 1 of 3 snake charmers bitten by large king cobras showed no signs of envenomation.
In addition to biting, some cobra species have a unique defense; they eject or spit jets of venom toward an enemy, usually at the eyes. The fangs of these species are specially modified with the discharge orifice on the anterior face rather than at the tip. The effective discharge range of a large snake is at least 3 m. The ringhals and certain African species of Naja are the most effective spitters, but the spitting behavior also is observed among some Asian Naja species.
Pathophysiology
Cobra envenomation is an extremely variable process. The envenomations of some species cause profound neurological abnormalities (eg, cranial nerve dysfunction, abnormal mental status, muscle weakness, paralysis, and respiratory arrest). With other snakes, local tissue damage is of primary concern.
Necrosis is typical of bites by the African spitting cobras (Naja nigricollis, Naja mossambica, Naja pallida, and Naja katiensis), Naja atra (the Chinese cobra), Naja kaouthia (monocellate cobra), and Naja sumatrana (Sumatran spitting cobra). Although the venoms of these cobras contain neurotoxins, necrosis often is the chief or only manifestation of envenoming in humans. Occasionally, a combination of neurologic dysfunction and tissue necrosis is observed (Naja naja).
Cobra venoms have been studied extensively. As with all snake venoms, they are multicomponent systems whose toxins are mostly proteins and polypeptides.
Venoms can be divided into the following categories:
- With most species, excluding some of the African spitting cobras, the most clinically significant toxins are postsynaptic neurotoxins that competitively bind to nicotinic acetylcholine receptors to produce depolarizing neuromuscular blockade. One group in this category has 60-62 amino acids and 4 disulfide bridges. Another has 71-74 amino acids and 5 disulfide bridges.
- The second venom category comprises so-called cardiotoxins, which are actually generalized cell-membrane poisons that produce irreversible cell depolarization. Such depolarization may cause dysrhythmia, hypotension, and death.
- Toxins in the third category activate complement via the alternative pathway (C3-C9 sequence).
- The fourth category is composed of enzyme toxins, such as phospholipase A2 (variable toxicity), hyaluronidase (facilitates tissue dispersion of other toxins), L -amino acid oxidase (gives many venoms a characteristic yellow coloration), and acetylcholine acetylhydrolase (unknown toxicity). Other proteolytic enzymes are found in the venom of the king cobra.
Naja philippinensis (Philippine cobra) venom is the most toxic, with a subcutaneous median lethal dose (LD50) of 0.14 mg/kg in mice. In comparison, the corresponding LD50 for Naja naja (Indian cobra) venom is 0.29 mg/kg, for Naja haje (Egyptian cobra) venom is 1.75 mg/kg, for king cobra venom is 1.73 mg/kg, and for Naja nigricollis (black-necked spitting cobra) venom is 3.05 mg/kg.
An additional, unique form of toxicity with some Asian and African species is acute ophthalmia, which occurs when venom is spit into the eyes. Spitting cobras can spit venom into a person's eyes from up to 3 m away. Immediate and intense pain results, with blepharospasm, tearing, and blurring of vision. Systemic toxicity does not occur with eye exposure, but corneal ulcerations, uveitis, and permanent blindness have been reported in untreated cases.
About half of the cases ascribed to the African spitting cobras (N nigricollis, N mossambica, N pallida, N katiensis) showed corneal ulceration, and some patients experienced permanent visual impairment or blindness. Cases ascribed to the Asian spitting cobras and the African ringhals are usually less severe.
Frequency
United States
Envenomations result from human interaction with cobras in zoos, research laboratories, and private collections in the United States and other countries where cobras lack natural habitat. In a series of 54 consultations regarding bites by non-native snakes in the United States, 23 involved cobras. One fatality occurred, and 7 other cases involved serious envenoming. In Russell's 1980 series, cobras inflicted 18 of the 85 bites by non-native snakes.1 No comparable data are available for other nations, though it was reported that only 3 cobra bites among 32 bites inflicted by non-native venomous snakes occurred in Britain (rattlesnakes were implicated most often in this series).
International
Snakebites are a significant medical problem in parts of Africa and Asia. In West Africa, the annual bite incidence is 40-120 bites per 100,000 population. Two rural Congolese regions report an annual incidence of 430 bites per 100,000 population. In a 7-year survey, the Natalese incidence was 24 bites per 100,000 population.
Mortality/Morbidity
In India, the annual mortality incidence is 5.6-12.6 per 100,000 population. At one time, Burma listed snakebite as its fifth leading cause of death. More recently, the annual mortality incidence was 3.3 per 100,000 population. Data from Thailand and Malaysia in the 1980s demonstrate an annual mortality incidence of 0.1 per 100,000 population.
- Determining the exact contribution of cobras to overall snakebite morbidity and mortality is difficult. In most cases, bitten individuals are unable to identify the snake. In India, the tendency is to ascribe all fatal or serious bites to cobras. Physicians are also likely to attribute all bites with neurotoxic symptoms to cobras.
- In a Thai survey, cobras made up 17% of the 1145 snakes identified in bites and were responsible for 25% of the fatalities associated with those bites. In northern Malaysia, cobras accounted for 23 of 854 bites in which the snake was identified. In a survey in Taiwan, cobras were blamed for 100 of 851 bites in which the snake was identified; none was fatal. Cobras accounted for 2 of 95 bites on a Liberian rubber plantation. The ringhals was responsible for 18 of 314 envenomations in Natal. Based on patients' symptoms alone, 18 other bites in this series were ascribed to cobras.
- King cobra bites are considered more serious than bites from other cobra species because of the greater volumes of injected venom and the more rapid onset of neurotoxic symptoms. Mortality is also higher. In a series of 35 cases, 10 deaths occurred. Ringhals bites are similar to other cobra bites but are less serious both locally and systemically. Deaths are rare. A medical report of 4 bites by the desert black snake described relatively mild symptoms and reported recovery without specific treatment. Anecdotal reports of fatal bites exist. No medical accounts of bites by water cobras or tree cobras exist. Anecdotal evidence suggests both are dangerous.
Sex
Because of increased exposure to snakes, men are bitten more often than women.
Clinical
History
The onset of symptoms and signs following a cobra bite can be extremely variable.
- Immediate, local pain (almost always present)
- Soft tissue swelling (may be progressive)
- Neurologic findings, which may begin early and be rapidly progressive (in anecdotal cases, victims have suffered respiratory arrest in a matter of minutes) or may be delayed in onset as long as 24 hours
- Alteration of mental status (eg, drowsiness, occasionally with euphoria)
- Complaints related to cranial nerve dysfunction, such as ptosis (often one of the earliest neurotoxic findings), ophthalmoplegia, dysphagia, and dysphasia
- Profuse salivation, nausea, vomiting, and abdominal pain
- Paresis of neck and jaw muscles and generalized muscular weakness followed by flaccid paralysis
- Shortness of breath, respiratory failure (muscular paresis and accumulated secretions)
- Chest pain or tightness
- Eye pain, tearing, blurred vision (with eye exposure to venom from spitting cobras)
Physical
- Impending respiratory failure
- Respiratory distress or weakness
- Cyanosis
- Neurologic dysfunction
- Altered mental status
- Ptosis (may be the earliest sign of systemic toxicity)
- Generalized weakness or paralysis
- Cardiovascular collapse
- Hypotension
- Tachycardia or bradycardia
- Soft tissue edema
- Signs of necrosis usually appear within 48 hours of the bite.
- The area around the fang punctures darkens.
- Blistering may follow.
- Necrosis is usually confined to the skin and subcutaneous tissue but may be quite extensive.
- A putrid smell is characteristic.
- Acute inflammation of the eye follows venom-spitting exposure and is characterized by ocular congestion, edema of the conjunctiva and cornea, and a whitish discharge.
More on Snake Envenomation, Cobra |
Overview: Snake Envenomation, Cobra |
| Differential Diagnoses & Workup: Snake Envenomation, Cobra |
| Treatment & Medication: Snake Envenomation, Cobra |
| Follow-up: Snake Envenomation, Cobra |
| Multimedia: Snake Envenomation, Cobra |
| References |
| Next Page » |
References
Russell FE. Snake venom poisoning in the United States. Annu Rev Med. 1980;31:247-59. [Medline].
Bush SP, Hegewald KG, Green SM, et al. Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. Wilderness Environ Med. 2000;11(3):180-8. [Medline].
Gold BS. Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra. Ann Emerg Med. Jul 1996;28(1):87-9. [Medline].
Khandelwal G, Katz KD, Brooks DE, Gonzalez SM, Ulishney CD. Naja Kaouthia: two cases of Asiatic cobra envenomations. J Emerg Med. Epub 2007 Jan 17;32(2):171-4. [Full Text].
Lifshitz M, Maimon N, Livnat S. Walterinnesia aegyptia envenomation in a 22-year-old female: a case report. Toxicon. Mar 2003;41(4):535-7. [Medline].
Lim BL. Venomous land snakes of Malaysia. In: Chou LM, Gopalkrishnakone P, eds. Snakes of Medical Importance - Asia-Pacific Region. National of University of Singapore;1990:387-417.
Looareesuwan S, Viravan C, Warrell DA. Factors contributing to fatal snake bite in the rural tropics: analysis of 46 cases in Thailand. Trans R Soc Trop Med Hyg. 1988;82(6):930-4. [Medline].
Low BW, Corfield BWR. Acetylcholine receptor alpha-toxin binding site - theoretical and model studies. Asia Proc J Pharmacol. 1987;2:115-27.
Minton SA. Bites by non-native venomous snakes in the United States. Wilderness Environ Med. 1996;4:297-303.
Minton SA Jr. Paraspecific protection by elapid and sea snake antivenins. Toxicon. Jul 1967;5(1):47-55. [Medline].
Norris RL, Ngo J, Nolan K. Physicians and lay people are unable to apply pressure immobilization properly in a simulated snakebite scenario. Wilderness Environ Med. 2005;16(1):16-21. [Medline].
Reid HA. Bites by foreign venomous snakes in Britain. Br Med J. Jun 17 1978;1(6127):1598-1600. [Medline].
Reid HA. Cobra bites. Br Med J. 1964;2:540-545.
Reid HA, Thean PC, Martin WJ. Epidemiology of snake bite in north Malaya. Br Med J. 1963;1:992-997.
Sawai Y, Tseng CS. Snakebites on Taiwan. Snake. 1969;1:9-18.
Stahel E. Epidemiological aspects of snake bites on a Liberian rubber plantation. Acta Trop. Dec 1980;37(4):367-74. [Medline].
Tin-Myint, Rai-Mra, Maung-Chit, et al. Bites by the king cobra (Ophiophagus hannah) in Myanmar: successful treatment of severe neurotoxic envenoming. Q J Med. Sep 1991;80(293):751-62. [Medline].
Veto T, Price R, Silsby JF, Carter JA. Treatment of the first known case of king cobra envenomation in the United Kingdom, complicated by severe anaphylaxis. Anaesthesia. Jan 2007;62(1):75-8. [Full Text].
Viravan C, Looareesuwan S, Kosakarn W, et al. A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg. Jan-Feb 1992;86(1):100-6. [Medline].
Visser J, Chapman DS. Snakes and Snake-bite. 1978:1-152.
Walsh DS, Looareesuwan S, Wilairatana P, et al. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis. Oct 1999;180(4):1282-7. [Medline].
Warrell DA. Clinical toxicology of snakebite in Africa and the Middle East and Asia. In: Clinical Toxicology of Animal Venoms and Poisons. CRC Press;1995:433-594.
Warrell DA, Ormerod LD. Snake venom ophthalmia and blindness caused by the spitting cobra (Naja nigricollis) in Nigeria. Am J Trop Med Hyg. May 1976;25(3):525-9. [Medline].
Watt G, Padre L, Tuazon L, et al. Bites by the Philippine cobra (Naja naja philippinensis): prominent neurotoxicity with minimal local signs. Am J Trop Med Hyg. Sep 1988;39(3):306-11. [Medline].
Watt G, Theakston RD, Hayes CG, et al. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. N Engl J Med. Dec 4 1986;315(23):1444-8. [Medline].
Westhoff G, Tzschatzsch K, Bleckmann H. The spitting behavior of two species of spitting cobras. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. Oct 2005;191(10):873-81. [Medline].
Wongtongkam N, Wilde H, Sitthi-Amorn C. A study of Thai cobra (Naja kaouthia) bites in Thailand. Mil Med. Apr 2005;170(4):336-41. [Medline].
Further Reading
Keywords
snakebite, snake bite, cobra bite, snake venom, treatment, symptoms, cobra envenomations, snake envenomations, Naja, Naja philippinensis, Philippine cobra, Ophiophagus hannah, king cobra, Hemachatus haemachatus, ringhals, Walterinnesia aegyptia, desert black snake, Boulengerina, water cobra Pseudohaje, tree cobra






Overview: Snake Envenomation, Cobra